Published in Biochem J on July 01, 1996
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry (1988) 10.17
The reaction of no with superoxide. Free Radic Res Commun (1993) 5.65
Nitric oxide synthase structure and mechanism. J Biol Chem (1993) 3.74
Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem (1989) 3.42
Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J (1992) 2.68
Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry (1992) 2.65
Autoxidation kinetics of aqueous nitric oxide. FEBS Lett (1993) 2.47
N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem (1991) 2.38
Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci U S A (1993) 2.18
Nitric oxide: a new paradigm for second messengers. J Med Chem (1995) 1.94
Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci U S A (1994) 1.71
Hydrogen peroxide-supported oxidation of NG-hydroxy-L-arginine by nitric oxide synthase. Biochemistry (1995) 1.44
The reaction between the superoxide anion radical and cytochrome c. Biochim Biophys Acta (1975) 1.05
Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells. Proc Natl Acad Sci U S A (1991) 0.97
Cytochrome P450 catalyzes the oxidation of N omega-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrulline. Biochem Biophys Res Commun (1992) 0.96
On the mechanism of the nitric oxide synthase-catalyzed conversion of N omega-hydroxyl-L-arginine to citrulline and nitric oxide. J Biol Chem (1994) 0.93
Formation of nitrogen oxides and citrulline upon oxidation of N omega-hydroxy-L-arginine by hemeproteins. Biochem Biophys Res Commun (1992) 0.92
Electron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reduction. J Biol Chem (1994) 0.87
Exogenous NG-hydroxyl-L-arginine causes nitrite production in vascular smooth muscle cells in the absence of nitric oxide synthase activity. FEBS Lett (1994) 0.87
Nitric oxide in biological fluids: analysis of nitrite and nitrate by high-performance ion chromatography. J Chromatogr A (1995) 0.85
Radiation chemistry applied to drug design. Int J Radiat Biol (1994) 0.83
Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine. J Cardiovasc Pharmacol (1992) 0.80
Cytochrome P-450- and peroxidase-dependent activation of procarbazine and iproniazid in mammalian cells. Free Radic Res Commun (1991) 0.80
Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide. Biochem Pharmacol (1993) 0.80
Control of electron transfer in neuronal nitric oxide synthase by calmodulin, substrate, substrate analogs, and nitric oxide. Adv Pharmacol (1995) 0.79
Nitric oxide synthase: involvement of oxygen radicals in conversion of L-arginine to nitric oxide. Biochem Biophys Res Commun (1993) 0.79
The construction and performance of a low cost automated HPLC system for polyamine assay. J Chromatogr Sci (1980) 0.78
NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta. Biochem Biophys Res Commun (1992) 0.78
Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res (1976) 3.44
Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res (1999) 1.79
Drug malabsorption and resistant tuberculosis in HIV-infected patients. N Engl J Med (1995) 1.69
The use of nitroaromatic compounds as hypoxic cell radiosensitizers. Curr Top Radiat Res Q (1977) 1.63
Mammalian cell toxicity of nitro compounds : dependence upon reduction potential. Biochem Biophys Res Commun (1976) 1.53
Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. Int J Radiat Biol Relat Stud Phys Chem Med (1979) 1.47
Interaction of dGMP radical with cysteamine and promethazine as possible model of DNA repair. Nature (1974) 1.42
Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. Anticancer Res (2001) 1.32
Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol (1988) 1.28
Kinetics and mechanisms of hypochlorous acid reactions. Arch Biochem Biophys (1995) 1.28
Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers. Radiother Oncol (1992) 1.27
Smoking in help-seeking veterans with PTSD returning from Afghanistan and Iraq. Addict Behav (2008) 1.24
Oxygen inhibition of nitroreductase: electron transfer from nitro radical-anions to oxygen. Biochem Biophys Res Commun (1976) 1.20
Cytochrome C is a potent catalyst of dichlorofluorescin oxidation: implications for the role of reactive oxygen species in apoptosis. Biochem Biophys Res Commun (2001) 1.19
The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys (1988) 1.17
Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett (1993) 1.17
Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: dependence on reduction potential. J Natl Cancer Inst (1980) 1.14
Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer (1991) 1.11
The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse. Br J Cancer (1983) 1.08
Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochem Pharmacol (2001) 1.07
Neurotoxicity with desmethylmisonidazole. Br J Radiol (1981) 1.06
Cellular uptake of misonidazole and analogues with acidic or basic functions. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.02
In vivo assessment of basic 2-nitroimidazole radiosensitizers. Br J Cancer (1982) 1.00
Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem (1992) 1.00
Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio. Int J Radiat Biol Relat Stud Phys Chem Med (1979) 0.98
Clinical pharmacokinetics of newer cephalosporins. Clin Pharmacokinet (1995) 0.98
Radiosensitization of Serratia marcescens by bipyridinium compounds. Int J Radiat Biol Relat Stud Phys Chem Med (1977) 0.97
A drug for improved radiosensitization in radiotherapy. Br J Cancer (1980) 0.96
Free-radical repair by a novel perthiol: reversible hydrogen transfer and perthiyl radical formation. Free Radic Res (1994) 0.96
Radicals from one-electron reduction of nitro compounds, aromatic N-oxides and quinones: the kinetic basis for hypoxia-selective, bioreductive drugs. Biochem Soc Symp (1995) 0.95
Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet (2000) 0.95
A serial study of the concentration of misonidazole in human tumors correlated with histologic structure. Int J Radiat Oncol Biol Phys (1981) 0.95
Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br J Cancer (2000) 0.95
Kinetics of superoxide scavenging by glutathione: an evaluation of its role in the removal of mitochondrial superoxide. Biochem Soc Trans (2003) 0.94
Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy (1998) 0.93
Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron(II) complex. Free Radic Res (1994) 0.93
Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide. Cancer Res (1995) 0.93
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid. Br J Cancer (1981) 0.93
Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther (2000) 0.93
Factors controlling the substrate specificity of peroxidases: kinetics and thermodynamics of the reaction of horseradish peroxidase compound I with phenols and indole-3-acetic acids. Biochemistry (1997) 0.92
Measurement of oxygen tension in tumours by time-resolved fluorescence. Br J Cancer Suppl (1996) 0.92
Perthiols as antioxidants: radical-scavenging and prooxidative mechanisms. Methods Enzymol (1995) 0.92
The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion. Br J Cancer (1997) 0.91
Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug. Anticancer Drug Des (1998) 0.91
One-electron reduction of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents. J Med Chem (1986) 0.91
Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapy. Acta Oncol (1996) 0.90
Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions. Mol Cancer Ther (2001) 0.90
Some reactions and properties of nitro radical-anions important in biology and medicine. Environ Health Perspect (1985) 0.89
Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity. Int J Radiat Oncol Biol Phys (1995) 0.89
Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor. Radiat Res (1997) 0.89
Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. Br J Cancer (1995) 0.89
Enhancement of lipid peroxidation by indole-3-acetic acid and derivatives: substituent effects. Free Radic Res (1995) 0.89
Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents. Clin Chim Acta (2001) 0.88
High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine. J Chromatogr (1992) 0.88
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 0.87
Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues. Br J Cancer (1989) 0.87
Clinical experience with nitroimidazoles as radiosensitizers. Int J Radiat Oncol Biol Phys (1982) 0.87
Factors influencing the chemosensitization of melphalan by misonidazole. Br J Cancer (1985) 0.87
Effect of anemia on tumor radiosensitivity under normo and hyperbaric conditions. Int J Radiat Oncol Biol Phys (1987) 0.87
Peroxidase-catalyzed effects of indole-3-acetic acid and analogues on lipid membranes, DNA, and mammalian cells in vitro. Biochem Pharmacol (1999) 0.87
Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro. Br J Cancer (1979) 0.87
Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours. Exp Physiol (1997) 0.87
Toward targeted "oxidation therapy" of cancer: peroxidase-catalysed cytotoxicity of indole-3-acetic acids. Int J Radiat Oncol Biol Phys (1998) 0.86
Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains. Int J Radiat Biol Relat Stud Phys Chem Med (1980) 0.86
Ruby laser irradiation (694 nm) of human skin biopsies: assessment by electron spin resonance spectroscopy of free radical production and oxidative stress during laser depilation. Photochem Photobiol (1999) 0.86
A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799. Br J Radiol (1986) 0.85
Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br J Cancer (1997) 0.85
Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro. J Med Chem (1998) 0.85
Radiosensitization by non-nitro compounds. Int J Radiat Oncol Biol Phys (1982) 0.85
Nitric oxide in biological fluids: analysis of nitrite and nitrate by high-performance ion chromatography. J Chromatogr A (1995) 0.85
The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations. Int J Radiat Oncol Biol Phys (1984) 0.84
Fluorescent markers of hypoxic cells: a comparison of two compounds on three cell lines. Br J Radiol (1985) 0.84
Phase I study of intravenous 4-hydroxyanisole. Eur J Cancer (1992) 0.83
Free radical intermediates in the oxidation of flavone-8-acetic acid: possible involvement in its antitumour activity. Free Radic Biol Med (1993) 0.83
Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration. Int J Radiat Biol Relat Stud Phys Chem Med (1983) 0.83
The measurement of hypoxia in tumours. BJR Suppl (1992) 0.83
Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase. Biochem Pharmacol (1980) 0.83
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. Radiother Oncol (1998) 0.83